As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...

Objective: To assess health care practitioners' ability to correctly measure the QT interval, and to identify factors and medications that may increase the risk of QT-interval prolongation and ...

The diagnostics advisory committee considered evidence on KardiaMobile 6L for measuring QT interval from several sources, including an early value assessment report, cost and resource use report and ...

AliveCor's at-home EKG device won FDA clearance to calculate a heart's QT interval, a measurement of how long it takes the ventricles to contract and relax. This is vital given that some drugs can ...

AliveCor is also offering a service called InstantQT™ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...

Please provide your email address to receive an email when new articles are posted on . AliveCor announced it received FDA 510(k) clearance for its mobile, handheld ECG device for the calculation of a ...

The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending KardiaMobile 6L for measuring cardiac QT interval in people on antipsychotic medication. "It is the ...

the effectiveness (diagnostic accuracy) of using KardiaMobile 6L to measure QT interval in adults having or about to have antipsychotic medications and the effect of the corrected QT interval (QTc) ...